Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: Correlations with clinical parameters and survival

Japanese Journal of Clinical Oncology

Volumn 34, Issue 4, 2004, Pages 184-190

  Kim, Seok Jin ^a   Choi, In Keun ^a   Park, Kyong Hwa ^a   Yoon, So Young ^a   Oh, Sang Cheul ^a   Seo, Jae Hong ^a   Choi, Chul Won ^a   Kim, Byung Soo ^a   Shin, Sang Won ^a   Kim, Yeul Hong ^a   Kim, Jun Suk ^a  

^a Korea University Ansan Hospital   (South Korea)

Author keywords

Hepatocellular carcinoma (HCC); Platelet count; Vascular endothelial growth factor

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; PROGNOSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THROMBOCYTE COUNT; TUMOR VOLUME; VEIN THROMBOSIS; BLOOD; CHEMOEMBOLIZATION; LIVER TUMOR; MIDDLE AGED; MORTALITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18344402517     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh039     Document Type: Article

References (24)

1. Li XM, Tang ZY, Liu YK, Ye SL. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 1998;17:13-7.
2. Dvorak HF, Brown IF, Detmar M, Dvorak AM. Vascular permeability factor/ vascular endothelial growth factor, microvascular hypermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.
3. Poon RT, Ng IO, Lau C, Zhu LX, Yu WC, Lo CM, et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: A prospective study. Ann Surg 2001;233:227-35.
4. Salven P, Ruotsalainen T, Mattson K, Joensuu H. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer 1998;79:144-6.
5. O'Byrne JK, Dobbs N, Propper D, Smith K, Harris AL. Vascular endothelial growth factor, platelet counts, and prognosis in renal cancer. Lancet 1999;353:1494-5.
6. Akbulut H, Altuntas F, Akbulut KG, Ozturk G, Cindoruk M, Unal E, et al. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma. Cytokine 2002;20:184-90.
7. Karayiannakis AJ, Bolanaki H, Syrigos KN, Asimakopoulos B, Polychronidis A, Anagnostoulis S, et al. Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis. Cancer Lett 2003;194:119-24.
8. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956-64.
9. Webb NJA, Bottomley MJ, Watson CJ, Brenchley PEC. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci 1998;94:395-404.
10. Vermeulen PB, Salven P, Benoy I, Gasparini G, Dirix LY. Blood platelets and serum VEGF in cancer patients. Br J Cancer 1999;79:370-6.
11. Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer 1999;80: 892-7.
12. Handagama PJ, George JN, Shuman MA, McEver RP, Bainton DF. Incorporation of a circulating protein into megakaryocyte and platelet granules. Proc Natl Acad Sci USA 1987;84:861-5.
13. Salven P, Orpana A, Joensuu H. Leukocytes and platelets with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 1999;5:487-91.
14. Benoy I, Salgado R, Colpaert C, Weytjens R, Vermeulen PB, Dirix LY. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2002;2:311-5.
15. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging? Clin Cancer Res 2000;6:3147-52.
16. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 2nd edn. Tokyo: Kanehara 2003;23.
17. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlation with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-8.
18. Amaya H, Tanigawa N, Lu C, Matsumura M, Shimomatsuya T, Horiuchi T, et al. Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/ platelet-derived endothelial cell growth factor expression in human colorectal cancer. Cancer Lett 1997;119:227-35.
19. Cox G, Walker RA, Andi A, Steward WP, O'Bryne KJ. Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer. Lung Cancer 2000;29:169-77.
20. Gücer F, Moser F, Tamussino K, Reich O, Haas J, Arikan G, et al. Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol 1998;70:2104.
21. Verheul HM, Hoekman K, Luykx-de Bakker S, Eelanan CA, Folman CC, Broxterman HJ, et al. Platelet: Transporter of vascular endothelial growth factor. Clin Cancer Res 1997;3:2187-90.
22. Harrison P, Wilbourn B, Debil N, Vainchenker W, Breton-Gorius J, Lawrie AS, et al. Uptake of plasma fibrinogen into a granules of human megakaryocytes and platelets. J Clin Invest 1989;84:1320-4.
23. Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM, Voelkel NF, et al. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1995;275:1054-61.
24. Trikha M, Nakada MT. Platelets and cancer: Implications for anti-angiogenic therapy. Semin Thromb Hemos 2002;28:39-44.